z-logo
open-access-imgOpen Access
Th17 Cells: Can Epigenetic Manipulation and Artificial T cell Receptors Make Th17 cells Efficient Immunotherapeutic Anti-Tumor Effector T Cells?
Author(s) -
Michael P. Alexander
Publication year - 2016
Publication title -
moj immunology
Language(s) - English
Resource type - Journals
ISSN - 2373-4442
DOI - 10.15406/moji.2016.04.00119
Subject(s) - immunopharmacology , effector , tumor immunology , receptor , microbiology and biotechnology , epigenetics , biology , immunotherapy , immunology , immune system , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom